China - Half Way Up the Value Chain

A conversation with Charles Hsu, Ph.D., Venture Partner, Bay City Capital (Part I)
Recorded on: November 7, 2008
Runtime: 00:23:24

In this segment, Charles Hsu discusses China's R&D capabilities, the rise of China's biotech industry, and its implications on the U.S. and China healthcare markets. More...

Tags: China biotech, Charles Hsu, Shanghai, Beijing, Suzhou, Tianjin, Wuxi Pharmatech, LEAD, Bay City Capita